Skip to content

TB-500 (Thymosin Beta-4)

Research Use Only
peptideInjection

Synthetic Thymosin Beta-4, a protein that drives cell migration and tissue repair. Promotes angiogenesis, reduces inflammation, and supports tissue remodeling body-wide. Popular for injury recovery.

Key Facts

  • Classification
    Thymosin Beta-4 is a 43-amino acid polypeptide that sequesters G-actin monomers, regulating actin polymerization for cell migration and tissue remodeling.
  • Primary Benefits
    Injury Healing (9/10) · Inflammation (8/10) · Muscle Growth (5/10)
  • Administration
    Injection
  • Typical Dose
    Loading phase: 2-5 mg subq twice a week for 4 weeks. Then drop to 2 mg twice a week for maintenance.
  • Evidence Strength
    Moderate — 20 peer-reviewed studies referenced · Community sentiment 9/10
  • Stacks Well With
    BPC-157, GHK-Cu, SS-31, NAD+
  • Legal Status
    Research Use Only · not prescribable in US · WADA prohibited

Quick Facts

From price
$35
Type
peptide
Administration
Injection
Evidence
moderate
Studies referenced
20
Community sentiment
9/10
Stacks with
5 peptides
Regulatory
Research Use Only

Top benefits

🩹 Injury Healing
9/10
🧊 Inflammation
8/10
💪 Muscle Growth
5/10
1

Week 1–2

Subtle reduction in systemic inflammation. Injury sites may feel slightly less stiff. Loading dose period — effects are accumulating.

2

Week 3–6

Improved flexibility and range of motion at injury sites. Visible wound healing acceleration. Reduced swelling in chronic injuries.

3

Week 8+

Significant tissue remodeling and repair. New blood vessel formation in previously poorly-vascularized injuries. Sustained anti-inflammatory benefits.

Common Side Effects

Injection site irritationTemporary lethargyHead rush (rare)Mild flu-like symptoms during loading
Tolerance: Not well-characterized — switch to maintenance dose after loading phase
Cycling: 4-week loading phase, then 4-8 weeks maintenance. 4 weeks off between cycles.

Scientific Overview

Thymosin Beta-4 is a 43-amino acid polypeptide that sequesters G-actin monomers, regulating actin polymerization for cell migration and tissue remodeling. Promotes angiogenesis through VEGF upregulation. Anti-inflammatory properties stem from NF-κB inhibition and reduced pro-inflammatory cytokines (IL-1β, TNF-α). Crosses the blood-brain barrier with demonstrated neuroprotective properties.

Dosing

Loading phase: 2-5 mg subq twice a week for 4 weeks. Then drop to 2 mg twice a week for maintenance.

Reconstitution, storage, injection sites & timing

Benefit Profile

🩹 Injury Healing
9/10
🧊 Inflammation
8/10
💪 Muscle Growth
5/10
Skin & Hair
5/10
🛡️ Immune Support
3/10
Medical oversight recommendedNot safe during pregnancy· 3 contraindications